100% accuracy
of data
of data
24/7 scientific
support
support
0% tolerance in
quality of product
quality of product
Stock Locations
- New Jersey, USA
- Czech Republic, EU
- Mumbai, India
* Stock subject to availability.
Documentation
Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.
167997-12-817α,21-Dideoxy-6α,9α-Difluoroprednisolone
● In Stock
| Catalogue No.: | VE008763 |
|---|---|
| CAS No.: | 167997-12-8 |
| Mol. Formula: | C20H24F2O4 |
| Mol. Weight: | 366.40 g/mol |
Additional information on CAS 167997-12-8
Parent drug
DifluoroprednisoloneIUPAC Name
(6S, 8S, 9R, 10S, 11S, 13S, 14S, 17S)-6, 9-difluoro-11-hydroxy-10, 13-dimethyl-3-oxo-6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17-dodecahydro-3H-cyclopenta[a]phenanthrene-17-carboxylic acidSynonyms
N/ADescription
17a,21-Dideoxy-6a,9a-Difluoroprednisolone is an impurity of Difluprednate is a corticosteroid, It is chemically a butyrate ester of 6(alpha),9(alpha)-difluoro prednisolone acetate. Accordingly, difluprednate is sometimes abbreviated DFBA, for difluoroprednisolone butyrate acetate.References
https://www.facebook.com/Drugscom. “FDA Approves Durezol.” Drugs.com, Drugs.com, 2022, www.drugs.com/newdrugs/sirion-therapeutics-announces-fda-approval-durezol-treatmentof-postoperative-ocular-inflammation-1031.html.Request a Quote
"*" indicates required fields
Other products related to Difluoro prednisolone impurities
Impurity structure
Parent Drug Name
CAS No.
Name of Impurity
Catalog No.
